Variant report
Variant | nsv521846 |
---|---|
Chromosome Location | chr5:111432013-111444522 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:111427178..111429315-chr5:111442008..111443800,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs27409 | chr5:111432013-111432014 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs542118818 | chr5:111432030-111432031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs534346047 | chr5:111432040-111432041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562937734 | chr5:111432064-111432065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555050914 | chr5:111432068-111432069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs180897108 | chr5:111432102-111432103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs114221006 | chr5:111432138-111432139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7731519 | chr5:111432144-111432145 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs557636129 | chr5:111432155-111432156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs575741462 | chr5:111432164-111432165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539983102 | chr5:111432191-111432192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs7731670 | chr5:111432212-111432213 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs185180594 | chr5:111432259-111432260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs374772202 | chr5:111432271-111432272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs145046770 | chr5:111432278-111432279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561731046 | chr5:111432291-111432292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs574416720 | chr5:111432313-111432314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141551534 | chr5:111432366-111432367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147049189 | chr5:111432368-111432369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs530625422 | chr5:111432379-111432380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs371634433 | chr5:111432420-111432421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375988249 | chr5:111432422-111432423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564044248 | chr5:111432439-111432440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs27983 | chr5:111432481-111432482 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs546650232 | chr5:111432496-111432497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191125760 | chr5:111432528-111432529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs27413 | chr5:111432540-111432541 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs551306196 | chr5:111432555-111432556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs527449207 | chr5:111432597-111432598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs27412 | chr5:111432675-111432676 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs539665713 | chr5:111432677-111432678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558296490 | chr5:111432704-111432705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375481802 | chr5:111432711-111432712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528211251 | chr5:111432723-111432724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183498600 | chr5:111432741-111432742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs147665674 | chr5:111432762-111432763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs186387284 | chr5:111432794-111432795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs573686027 | chr5:111432806-111432807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs544158129 | chr5:111432810-111432811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs28037 | chr5:111432894-111432895 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs575463228 | chr5:111432897-111432898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs377407112 | chr5:111432959-111432960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs142472549 | chr5:111432978-111432979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs370159290 | chr5:111433020-111433021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs191747853 | chr5:111433023-111433024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs535701889 | chr5:111433106-111433107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550941602 | chr5:111433120-111433121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs528242971 | chr5:111433154-111433155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs148356841 | chr5:111433210-111433211 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs561727255 | chr5:111433215-111433216 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 16573809 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:111429200-111443400 | Weak transcription | Aorta | Aorta |
2 | chr5:111429200-111456200 | Weak transcription | Pancreas | Pancrea |
3 | chr5:111433200-111433400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr5:111433400-111433600 | Enhancers | Osteobl | bone |
5 | chr5:111433400-111433800 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr5:111433400-111434000 | Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr5:111433400-111434000 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr5:111433600-111434000 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr5:111433600-111434000 | Flanking Active TSS | Osteobl | bone |
10 | chr5:111433800-111434000 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr5:111434000-111434200 | Flanking Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
12 | chr5:111434000-111434400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr5:111439000-111439600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr5:111441000-111441200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr5:111442400-111443000 | Enhancers | Primary monocytes fromperipheralblood | blood |
16 | chr5:111442800-111443000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
17 | chr5:111443000-111444800 | Weak transcription | Primary monocytes fromperipheralblood | blood |
18 | chr5:111443200-111445800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr5:111443400-111444000 | Enhancers | Aorta | Aorta |